That equalizes prices, brings revenues to the pharma industry. And you're on. The best evidence I have that what we've done is reasonable is that The market cap, the value of the stocks of the pharmaceutical companies have not plummeted. In fact, they seem to have gone up a little bit since these negotiations have been consummated. So it gives all of us confidence this is a sustainable process. And we've spoken to the leaders of the pharmaceutical industry and they're willing to work with Congress to try to figure out a solution. (20:49–21:01)
CLAIM
Asserts that pharmaceutical company stock values have increased following drug pricing negotiations.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
